Bo WU

Dr. Bo WU


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2024 in Journal of Infection
Verified
Journal Article
Open access
RGRong Gao
Rong Gao
WWWenjing Wang
Wenjing Wang
TQTing Qian
Ting Qian
XLXiaoshan Li
Xiaoshan Li
HYHang Yang
Hang Yang
BWBo WU
Bo WU
To explore the risk factors for pulmonary bacterial infection (PBI) after lung transplantation (LTX), and to evaluate the impact of PBI on the short-term postoperative mortality. We retrospectively analyzed data on 549 recipients who underwent LTX at the Affiliated Wuxi People's Hospital of Nanjing Medical University, China, between January 2018 and December 2021. The risk factors for PBI after LTX were explored by univariate analysis and multivariate logistic regression. Cox proportional hazards regression models were used to estimate the hazard ratios (HR) and 95% confidence intervals (CI) of one-, two-, and three-year mortality. Subgroup analysis was performed by the time of postoperative PBI (≤7 days or 8-30 day after surgery). The incidence of postoperative PBI in 549 recipients was 82.70% (454/549). Preoperative history of infections with multidrug-resistant bacteria (OR 12.34, 95% CI 1.69-1572.39), Acinetobacter baumannii infection in donor (OR 3.08, 95% CI 1.26-9.66), and longer cold ischemia time (OR 1.16, 95% CI 1.03-1.32) were risk factors for postoperative PBI. Postoperative PBI was associated with one-year (HR 1.80, 95% CI 1.09-2.96), two-year (HR 1.91, 95% CI 1.20-3.04), and three-year mortality (HR 2.03, 95% CI 1.29-3.19). Subgroup analysis showed that PBI within 7 days after surgery was associated with one-year (HR 1.86, 95% CI 1.12-3.08), two-year (HR 1.99, 95% CI 1.25-3.17), and three-year mortality (HR 2.13, 95% CI 1.35-3.36), while PBI at 8-30 days after surgery was not associated with short-term mortality (one-year: HR 1.36, 95% CI 0.69-2.69; two-year: HR 1.48, 95% CI 0.80-2.76; three-year: HR 1.51, 95% CI 0.82-2.77). Donor-recipient and surgical factors are risk factors for PBI after LTX. Active prevention and treatment of PBI within the first 7 days after surgery may improve short-term survival.

2 April 2024 in Microbiology Spectrum
Verified
Journal Article
Open access
ZHZhichao Hou
Zhichao Hou
TZTangjuan Zhang
Tangjuan Zhang
ZDZheng Ding
Zheng Ding
TQTing Qian
Ting Qian
PWPeng Wang
Peng Wang
XLXiangnan Li
Xiangnan Li
Previous studies have shown that the gut microbiota and its metabolites are associated with the success of organ transplantation. However, the specific changes in the gut microbiota of lung transplant patients remain unclear. Hence, this study aimed to elucidate the interplay between the gut microbiota, metabolome, and lung transplantation outcomes. Using 16S metagenomics sequencing and untargeted metabolic profiling, we conducted a comprehensive analysis of gut microbial and metabolic alterations in lung transplant recipients relative to non-transplant group. Our findings revealed the predominance of Enterococcus and Streptococcus genera within the lung transplant cohort, accompanied by the significant reduction in Bacteroides , Epulopiscium , Faecalibacterium , and Prevotella abundance. In addition, a significant reduction in ATRA (all-trans retinoic acid) levels and suppression of IgA production were observed in lung transplant recipients, which were found to be closely associated with the Enterococcus genus. It was speculated that the association might have implications for the prognosis of lung transplant patients. Notably, the differences in gut microbial composition and metabolomic profiles between successful transplant recipients and those experiencing chronic rejection were not statistically significant. These novel insights shed light on the putative implications of the gut microbiota and metabolome in shaping lung transplantation outcomes, and provide a foundation for future investigations and targeted therapeutic interventions. IMPORTANCE: This study has profound implications for lung transplantation as it uncovers the important role of gut microbiota and metabolome in shaping transplantation outcomes. The identification of dominant bacterial genera, such as Enterococcus and Streptococcus , within the lung transplant cohort, along with the significant decrease in Bacteroides , Epulopiscium , Faecalibacterium , and Prevotella abundance, reveals potential microbial imbalances associated with lung transplantation. In addition, a significant reduction in ATRA (all-trans retinoic acid) levels and suppression of IgA production were observed in lung transplant recipients, which were found to be closely associated with the Enterococcus genus. It was speculated that the association might have implications for the prognosis of lung transplant patients. These findings hold immense clinical significance as they lay the groundwork for future research and targeted therapeutic interventions. Understanding the impact of the gut microbiota and metabolome on lung transplantation outcomes offers promising avenues for improving transplantation patient prognosis.

20 April 2026 in Respiratory Research
Verified
Journal Article
Open access
PDF file
YLYaru Liu
Yaru Liu
LSLicheng Song
Licheng Song
YYYi Yang
Yi Yang
JLJia Liu
Jia Liu
WGWenjing Guo
Wenjing Guo
Lixin XieLixin Xie
Lixin Xie
Early adverse outcomes after lung transplantation often manifest as infection-associated clinical deterioration. Such events are closely intertwined with d

5 November 2024 in Asian Journal of Surgery
Verified
Journal Article
Open access
TLTianyang Liu
Tianyang Liu
YZYunxiang Zhang
Yunxiang Zhang
HYHang Yang
Hang Yang
XLXiaoshan Li
Xiaoshan Li
HWHongmei Wang
Hongmei Wang
BWBo WU
Bo WU
Background: Rapid On-Site Evaluation (ROSE) has been widely used in clinical applications. However, in the field of lung transplantation, there have been no comparative experiments to confirm and quantify its effectiveness. To this end, ROSE was used to detect donor lung infection or colonization and analyze its influence on the prognosis of lung transplantation. Methods: This study retrospectively analyzed 15 patients who received our center from March 2023 to May 2023. Fibrobronchoscopy and ROSE of bronchoalveolar lavage fluid(BALF) were performed. Postoperative survival rate index was collected for prognostic analysis. The coincidence rate of ROSE and traditional test culture was compared. Results: (1) The 15 BALF samples were divided into infection group and colonization group according to the presence of infection and phagocytosis.(2) The average time of ROSE report was 10.40 min, and the average time of Sputum culture test report was 4663 min, and the difference between the two groups was statistically significant (p < 0.01). (3) The results of ROSE's evaluation of donor lung infection were in good agreement with those of traditional Sputum culture, and the difference was statistically significant (p < 0.01). (4) There were no significant differences in postoperative survival rate index between the infection group and the colonization group after targeted antibiotics were applied in advance. Conclusion: ROSE has a high heterogeneity in the evaluation of donor lung transplantation infection. It can be used as one of the important auxiliary examination techniques before and after lung transplantation. (c) 2024 Asian Surgical Association and Taiwan Society of Coloproctology. Publishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/ by-nc-nd/4.0/).

24 June 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
YLYaru Liu
Yaru Liu
LSLicheng Song
Licheng Song
RSRuofan Su
Ruofan Su
KWKeruo Wang
Keruo Wang
DSDingyun Song
Dingyun Song
Lixin XieLixin Xie
Lixin Xie
Lung transplantation remains a life-saving option for patients with end-stage lung disease, yet long-term outcomes remain limited by chronic rejection and infection. Although T cells have historically been the focus of transplant immunology, B cells are now recognized as critical regulators of immune responses through the production of antibodies, antigen presentation, and cytokine secretion. These functions contribute to both protective immunity and antibody-mediated rejection (AMR), particularly in the form of donor-specific antibodies (DSAs), which drive chronic lung allograft dysfunction (CLAD). B cell dysregulation can result from ischemia-reperfusion injury (IRI), infection, and immunosuppressive agents such as tacrolimus (TAC), with distinct effects emerging across perioperative and late post-transplant phases. Advances in single-cell RNA sequencing and B cell receptor (BCR) repertoire profiling have enabled precise characterization of B cell dynamics, offering new opportunities for stratified immune monitoring and risk prediction. This review summarizes B cell biology in lung transplantation, outlines stage-specific perturbations, and explores how multi-omics technologies may support personalized immunomodulation and prognostic assessment.

16 May 2020
Verified
Book Chapter
Closed access
PDF file
JFJing Feng
Jing Feng
BWBo WU
Bo WU